AST5902 mesylate is a potent EGFR inhibitor that demonstrates significant antineoplastic activity. As a principal metabolite of Alflutinib, it plays a crucial role in the treatment of non-small cell lung cancer, effectively targeting activating EGFR mutations. Additionally, AST5902 mesylate shows promise in overcoming resistance associated with the EGFR T790M mutation, making it a valuable tool for cancer research and therapeutic development.
AST5902 mesylate is a potent EGFR inhibitor that demonstrates significant antineoplastic activity. As a principal metabolite of Alflutinib, it plays a crucial role in the treatment of non-small cell lung cancer, effectively targeting activating EGFR mutations. Additionally, AST5902 mesylate shows promise in overcoming resistance associated with the EGFR T790M mutation, making it a valuable tool for cancer research and therapeutic development.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
